WHY CANNMED?

The CannMed 25 Innovation and Investment Summit is a unique opportunity to explore, grow, and network with the greatest minds in cannabis science, medicine, cultivation, and safety testing from all around the world.

Since its inception at Harvard in 2016, CannMed has been a destination for the world’s top researchers, innovators, and investors to share novel findings, announce new technologies, and forge lasting connections. Here you can enhance your understanding of the therapeutic potential of the cannabis plant and learn from those who are driving the industry forward.

The summit includes interactive workshops that explore funding cannabinoid and cannabis innovation, applying the latest medical research, enhancing plant health and yield, and analyzing these important compounds. It also features oral and poster presentations that are selected based on relevance, novelty, clarity, and likelihood of generating conversation. Most importantly, the event includes dedicated networking sessions designed to stimulate collaboration and connection with fellow attendees, presenters, and sponsors.

CannMed 24 Featured Speakers

Some of the greatest minds in cannabis science and medicine

Ethan Russo, MD

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of CReDO Science Previously, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague, Czech Republic. Medical Director of PHYTECS (2015-2017), a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system, and from 2003-2014, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy.

View Bio

Zamir Punja, PhD

Zamir completed a BSc degree in Plant Sciences at the University of British Columbia in Vancouver, followed by MSc and PhD degrees in plant pathology from the University of California, Davis. He then joined the Campbell Soup Company and worked jointly with North Carolina State University in Raleigh on management of carrot diseases. He was appointed Manager of Plant Biotechnology research for Campbell’s in Davis, California to develop innovative methods for crop improvement.

His research interests include the etiology and management of plant diseases on vegetable and horticultural crops, and the applications of plant biotechnology for disease management.

View Bio

Bonni Goldstein, MD

Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. She completed her internship and residency at Children’s Hospital Los Angeles, where she also served as chief resident. After years of working in the specialty of Pediatric Emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend.

Over the last 15 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics.

View Bio

Jini Glaros, M.S.

Jini Glaros is the Chief Scientific Officer (CSO) at Modern Canna Labs in Lakeland, FL. She received her bachelor’s degree with honors in Biochemistry from the University of West Florida. In May of 2022, Jini earned a master’s degree in Medical Cannabis Science and Therapeutics from the University of Maryland, Baltimore. She became the laboratory director of Modern Canna in January of 2018 and was promoted to CSO in August of 2022.

Jini is extremely involved in the cannabis industry and currently serves on the Scientific Advisory Board for Analytical Cannabis and CloudLIMS, is a member of the CASP Proficiency Testing Advisory Task Force with AOAC International, is a member of the Cannabis Working Group (D37) with ASTM International, and is a member of the CannMed 2023 Advisory Board.

View Bio

View Full Speaker List

Sponsorship and Exhibitor Information

Sponsorship opportunities at CannMed 25 are as unique as the conference itself. Our team looks forward to crafting a sponsorship package for you and you alone, to support your brand, messaging and presence in the most powerful and appropriate ways. Please contact our team to get the conversation started.

BECOME A SPONSOR